Jean-Francois Formela - Director, Horizon Pharma, Inc

As of March 6, 2012


Jean-Francois Formela Net Worth

  • Net worth is estimated to be at least $746.9M
  • Owns at least 3,688,294 units of Horizon Pharma, Inc stock

Jean-Francois Formela Trading

  • Largest purchase of shares was 828,443 units , worth over $3M on March 6, 2012
  • In total has made about 1 transaction recently
  • Usually trades in March, with the busiest year in 2012
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jean-Francois Formela Mailing Address

  • Mailing address is C/o Atlas Venture 890 Winter Street Waltham MA 02451 MA

Horizon Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Timothy P. Walbert 2020 $1,146,542 - $199,548 $199,548 $199,548 $199,548 $21,632,803
Timothy P. Walbert 2019 $1,108,700 - $226,871 $226,871 $226,871 $226,871 $13,873,172
Timothy P. Walbert 2018 $1,076,250 - $160,363 $160,363 $160,363 $160,363 $16,796,894
Paul W. Hoelscher 2020 $600,569 - $106,485 $106,485 $106,485 $106,485 $5,915,146
Paul W. Hoelscher 2019 $580,748 - $120,135 $120,135 $120,135 $120,135 $4,443,588
Paul W. Hoelscher 2018 $563,750 - $104,332 $104,332 $104,332 $104,332 $7,034,386
Andy Pasternak 2020 $669,021 $250,000 $66,872 $66,872 $66,872 $66,872 $5,826,126
Andy Pasternak 2019 $108,333 $500,000 $19,188 $19,188 $19,188 $19,188 $2,924,542
Jeffrey W. Sherman, M.D., FACP 2020 $578,731 - $92,545 $92,545 $92,545 $92,545 $5,261,300
Jeffrey W. Sherman, M.D., FACP 2019 $559,630 - $95,222 $95,222 $95,222 $95,222 $3,568,496
Jeffrey W. Sherman, M.D., FACP 2018 $543,250 - $68,263 $68,263 $68,263 $68,263 $3,678,874
Barry J. Moze 2020 $628,960 - $75,659 $75,659 $75,659 $75,659 $5,073,877
Barry J. Moze 2019 $608,201 - $58,744 $58,744 $58,744 $58,744 $4,662,510
Barry J. Moze 2018 $590,400 - $35,114 $35,114 $35,114 $35,114 $2,732,565
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm

Horizon Pharma, Inc Insider Trading

  • The most recent transaction was 30,168 units sold on November 5, 2021 by Andy Pasternak worth over $3.41M
  • In the last 10 years, insiders at Horizon Pharma, Inc sold an estimated value of $513.33M and bought an estimated value of $104.65M
  • The most active traders are Timothy Walbert, Chairman,  Jeffrey Sherman, EVP and Chief Medical Officer,  and Barry Moze, EVP
  • Insider trading is most common in May, with the busiest year in 2021

Horizon Therapeutics Public Ltd Co Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1